Brett Stanaland, MD
Allergy · Naples, FLNPI 1508865924
Payments from drug & device makers
Across 865 payments — averaging $665.03 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- GSK$331K
- AstraZeneca$215K
- Incyte Corporation$11K
- Regeneron Healthcare Solutions, Inc.$8K
- Amgen$3K
- Optinose US, Inc.$2K
- plus $6K from 30 others
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| GSK | 321 | $331,116 |
| AstraZeneca | 239 | $214,638 |
| Incyte Corporation | 20 | $11,288 |
| Regeneron Healthcare Solutions, Inc. | 40 | $8,052 |
| Amgen(2 entities) | 12 | $2,533 |
| Optinose US, Inc. | 9 | $1,934 |
| Sanofi | 36 | $1,022 |
| Takeda Pharmaceuticals U.S.A., Inc. | 25 | $681 |
| Genentech USA, Inc. | 17 | $562 |
| CSL Behring | 19 | $484 |
| Grifols USA, LLC | 21 | $439 |
| Pfizer | 19 | $350 |
| Novartis | 17 | $319 |
| Covis Pharma GmbH | 14 | $291 |
| Kaleo, Inc. | 13 | $196 |
| Biocryst US Sales Co., LLC | 5 | $167 |
| ADMA Biomanufacturing LLC | 1 | $150 |
| Blueprint Medicines Corporation | 1 | $126 |
| Regeneron | 1 | $121 |
| Sanofi-aventis U.S. LLC | 2 | $121 |
| AbbVie | 5 | $115 |
| Shire North American Group Inc | 5 | $93 |
| Sunovion Pharmaceuticals Inc. | 5 | $88 |
| Teva Pharmaceuticals USA, Inc. | 4 | $84 |
| Pharming Healthcare, Inc. | 2 | $45 |
| Insmed, Inc. | 2 | $43 |
| Azurity Pharmaceuticals, Inc. | 1 | $28 |
| Boehringer Ingelheim | 1 | $25 |
| Bristol Myers Squibb | 1 | $24 |
| LEO Pharma Inc. | 1 | $19 |
| Mylan Specialty L.p. | 1 | $19 |
| Alk-abello, Inc | 1 | $18 |
| Verona Pharma, Inc. | 1 | $17 |
| Hikma Pharmaceuticals USA | 1 | $17 |
| Paratek Pharmaceuticals, Inc. | 1 | $16 |
| Phadia US Inc. | 1 | $15 |
How this compares
$575,255 in reported general payments places this provider in the 95th percentile of 56 allergy providers in Florida.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other allergy in Naples
- Hugh WindomSarasota$3.6M
- Miguel LanzCoral Gables$1.4M
- Alan KoterbaNorth Palm Beach$367K
- David RoseEglin Afb$253K
- Shahid RandhawaFort Lauderdale$91K
- Carlos PiniellaMiami$61K
- Pavana BeerelliRockledge$61K
- Patrick de MarcoOrange Park$23K
- Mark MinorMelbourne$21K
- Brian WilsonTallahassee$11K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.